Viewing Study NCT00096005


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2026-02-26 @ 12:05 PM
Study NCT ID: NCT00096005
Status: TERMINATED
Last Update Posted: 2014-02-24
First Post: 2004-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module